genOway Société anonyme (EPA:ALGEN)

genOway Société anonyme Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	20.96	23.75	21.54	18.36	15.79
Other Revenue	-	3.78	4.97	2.89	4
Revenue	20.96	27.53	26.51	21.25	19.79
Revenue Growth (YoY)	-23.88%	3.85%	24.76%	7.38%	21.30%
Cost of Revenue	-	12.81	10.67	9.3	9.39
Gross Profit	20.96	14.73	15.84	11.95	10.4
Selling, General & Admin	-	10.24	9.2	8.04	8.22
Other Operating Expenses	19.42	0.59	0.82	0.76	0.95
Operating Expenses	19.42	13.42	14.27	11.32	11.1
Operating Income	1.53	1.3	1.57	0.63	-0.7
Interest Expense	-0.29	-0.15	-0.11	-0.49	-0.27
Interest & Investment Income	-	0.06	0.02	0.17	0.25
Currency Exchange Gain (Loss)	-	0.05	0.09	-	-
Other Non Operating Income (Expenses)	-	0.32	0.01	-	-
EBT Excluding Unusual Items	1.25	1.59	1.58	0.31	-0.72
Gain (Loss) on Sale of Investments	-	-0.09	-0.03	-	-
Other Unusual Items	-	0.31	0	0.45	0.37
Pretax Income	1.25	1.81	1.55	0.76	-0.35
Income Tax Expense	0.32	-0.02	-0.02	-0.02	-0.03
Net Income	0.93	1.83	1.57	0.78	-0.32
Net Income to Common	0.93	1.83	1.57	0.78	-0.32
Net Income Growth	-49.31%	16.79%	101.55%	-	-
Gross Margin	100.00%	53.49%	59.74%	56.24%	52.56%
Operating Margin	7.32%	4.74%	5.90%	2.97%	-3.53%
Profit Margin	4.43%	6.65%	5.91%	3.66%	-1.63%
EBITDA	-	3.89	5.81	3.15	0.52
EBITDA Margin	-	14.14%	21.93%	14.82%	2.64%
D&A For EBITDA	-	2.59	4.25	2.52	1.22
EBIT	1.53	1.3	1.57	0.63	-0.7
EBIT Margin	7.32%	4.74%	5.90%	2.97%	-3.53%
Effective Tax Rate	25.70%	-	-	-	-
Revenue as Reported	-	27.66	26.59	21.4	19.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.